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The functional relationship between gangliosides and growth factor  receptors (GFRs) with tyrosine-kinase activity has already been extensively analysed. So far, no study has been performed in order to define the relation between gangliosides and the oncoprotein p185neu or its normal counterpart erbB2, although their well known involvement in the mammary adenocarcinoma development and in the mammary gland differentiation. 
The mouse mammary adenocarcinoma cell line MG1361, derived from mammary tumors of MMTV-neu transgenic mice, and the normal mouse mammary epithelial cell line HC11, in which erbB2 expression is inducible by the cell confluence degree in culture, are the experimental models analysed in the present study.
In the MG1361 cells, p185neu is constitutively in the phosphorylated active form, because of a single aminoacid substitution in the transmembrane domain (Val664Glu). 10 nM EGF was used to activate (auto-phosphorylation) the erbB2 receptor in HC11 cells. Inhibition of ganglioside biosynthesis in both the cell lines was achieved by 30 M D-PDMP treatment for five days. Gangliosides were analysed by HP-TLC. p185neu and erbB2 expression and phosphorylation were evaluated by western blot.
Our results demonstrate that, in HC11 cells, erbB2 and ganglioside GM3 expression raise together when increasing the degree of confluence of the cells. In EGF-stimulated HC11 cells, erbB2 is auto-phosphorylated, but its expression level decreases, as well as the ganglioside GM3 content, with respect to not-stimulated cells. Expression of other ganglioside species remains unchanged. Inhibition of ganglioside biosynthesis by D-PDMP treatment in EGF-stimulated HC11 cells does not interfere with the erbB2 auto-phosphorylation ability, but it maintains high expression levels of the receptor. On the contrary, in MG1361 cells, inhibition of ganglioside biosynthesis modifies nor p185neu expression neither its phosphorylation levels. 
These data give support to the hypothesis of a tight functional relationship between erbB2 and GM3 in HC11 cells. Both the molecules could co-localise at the plasma membrane level and the presence of GM3 could be of importance in the normal internalisation and turn-over of the activated receptor rather than in the receptor activation. It is to be further investigated if these two molecules are located within the glycosphingolipid enriched microdomains (GEM) and, if it is so, the nature of their molecular relationship.
The absence of a correlation between p185neu and ganglioside expression, in MG1361 cells, might be attributed to the nature of the oncoprotein, that is over-expressed and constitutively activated.

